Orchestra BioMed’s Hypertension Device Wins FDA Breakthrough Designation
Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. Medtronic has a commercialization deal with the company for the device, which uses a pacing algorithm to actively lower blood pressure in people with pacemakers. The post Orchestra BioMed’s Hypertension Device Wins FDA Breakthrough Designation appeared first on MedCity News.
Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. Medtronic has a commercialization deal with the company for the device, which uses a pacing algorithm to actively lower blood pressure in people with pacemakers.
The post Orchestra BioMed’s Hypertension Device Wins FDA Breakthrough Designation appeared first on MedCity News.
